Averna Therapeutics
Watertown, US · Founded 2022 · Delaware corporation · 2 known investors
Creates gene therapies that integrate therapeutic genes into patients' genomes to treat genetic disorders.
Healthtech
Founders & leadership
TB
Thomas BarnesChief Executive Officer/President
RM
Richard MorrisChief Financial Officer
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$85M disclosed across 1 round · 2024
▶$85MraisedMar 2026 · 13 investors · Other Health CareRule 506(b)
▶$85MraisedMar 2026 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas BarnesDirector, Executive Officer
- Roy AmariglioDirector
- Nick OlsenDirector
- Stephen SquintoDirector
- Richard MorrisExecutive Officer
- Michal SilverbergDirector
- Raju PrasadDirector
- Tal ZaksDirector, Executive Officer
- Henry ChenDirector
- Dylan MorrisDirector
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Averna Therapeutics do?
- Creates gene therapies that integrate therapeutic genes into patients' genomes to treat genetic disorders.
- Who are Averna Therapeutics's investors?
- Averna Therapeutics's investors include Deep Insight, OrbiMed.
- How much funding has Averna Therapeutics raised?
- Averna Therapeutics has disclosed $85M raised across 1 round.
- Where is Averna Therapeutics headquartered?
- Averna Therapeutics is headquartered in Watertown, US.


